Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
san francisco blog main
5
×
biotech
boston
boston top stories
clinical trials
fda
national top stories
new york blog main
deals
kaleido biosciences
new york top stories
startups
vc
akili interactive labs
akouos
astellas pharma
astellas pharmaceuticals
atlas venture
audentes therapeutics
avidity biosciences
azacitidine
beta-thalassemia
black diamond therapeutics
bladder cancer
bluebird bio
blueprint medicines
bruce leuchter
california institute for biomedical research
cancer
cancer drugs
click therapeutics
clickotine
dacogen
david benshoof klein
david klein
decibel therapeutics
deciphera pharmaceuticals
What
medicines
5
×
therapeutics
5
×
drug
ipo
biotech
developing
field
new
research
affects
ago
aims
americans
announced
approach
approved
backs
based
bets
biotechs
black
called
cancer
click
clinic
companies
considering
data
date
debuts
diamond
digital
diseases
drugs
dyne
early
eluded
epigenetic
epigenetics
example
Language
unset
Current search:
medicines
×
therapeutics
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
